Optune Pax
Jump to navigation
Jump to search
Indications
- treatment of locally advanced pancreatic cancer
Mechanism of action
- wearable device delivers alternating electric fields to the abdomen that disrupt cancer cells' ability to grow & divide, without significantly affecting healthy cells
Notes
- to be used concomitantly with gemcitabine & nab-paclitaxel (Abraxane)
More general terms
References
- ↑ Bassett M First-of-Its-Kind Device for Pancreatic Cancer Wins FDA Approval. First approved therapy for locally advanced disease in almost three decades. MedPage Today. February 12, 2026 https://www.medpagetoday.com/hematologyoncology/othercancers/119854